Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9- yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1487, Issue 2-3, 2000, Pages 201-208

  Singh, Amareshwar T K ^a   Radeff, Julie M ^a   Kunnel, Joseph G ^a   Stern, Paula H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Osteoblast; Parathyroid hormone; Phosphatidylcholine; Phospholipase C; Phospholipase D; Protein kinase C; Tricyclodecan 9 yl xanthogenate

Indexed keywords

PARATHYROID HORMONE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ANIMAL CELL; ARTICLE; DRUG EFFECT; HYDROLYSIS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BRIDGED COMPOUNDS; CHOLINE; DOWN-REGULATION; DRUG SYNERGISM; ENZYME INHIBITORS; HUMAN; HYDROLYSIS; ISOENZYMES; OSTEOSARCOMA; PARATHYROID HORMONES; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASE C; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; TEMPERATURE; THIONES; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0034721516     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(00)00096-2     Document Type: Article

References (24)

1. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:1995;484-496.
2. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 258:1992;607-614.
3. Exton J.H. Signaling through phosphatidylcholine hydrolysis. J. Biol. Chem. 265:1990;1-4.
4. Billah M.M., Anthes J.C. The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J. 269:1990;281-291.
5. 34]PTH-(3-34) amide, PTH-(1-31) amide, and PTH-related peptide-(1-34) stimulate phosphatidylcholine hydrolysis in UMR-106 osteoblastic cells: comparison with effects of phorbol 12,13-dibutyrate. Endocrinology. 140:1999;131-137.
6. Kiss Z., Crilly K.S., Chung T. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609). Biochem. Pharmacol. 55:1998;915-918.
7. Schutze S., Pothoff K., Machleidt T., Berkovic D., Wiegmann K., Kronke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell. 71:1992;765-776.
8. Halstead J., Kemp K., Ignotz R.A. Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-β signaling. J. Biol. Chem. 270:1995;13600-13603.
9. 3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler. Thromb. Vasc. Biol. 15:1995;1975-1986.
10. Wartmann M., Hofer P., Torowski P., Saltiel A.R., Hynes N.E. Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J. Biol. Chem. 272:1997;3915-3923.
11. Cai H., Erhardt P., Troppmair J., Diaz-Meco M.T., Sithanandam G., Rapp U.R., Moscat J., Cooper G.M. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol. Cell. Biol. 13:1993;7645-7651.
12. Cifone M.G., Roncaioli P., De Maria R., Camarda G., Santoni A., Ruberti G., Testi R. Multiple pathways originated at the Fas/Apo-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J. 14:1995;5859-5868.
13. Folch L., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:1957;497-509.
14. Tijburg L.B.M., Nishimaki-Mogami T., Vance D.E. Evidence that the rate of phosphatidylcholine catabolism is regulated in cultured rat hepatocytes. Biochim. Biophys. Acta. 1085:1991;167-177.
15. Sanders J.L., Stern P.H. Expression and phorbol ester-induced down-regulation of protein kinase C isozymes in osteoblasts. J. Bone Miner. Res. 11:1996;1862-1872.
16. Weinhold P.A., Rethy V.B. The separation, purification, and characterization of ethanolamine kinase and choline kinase from rat liver. Biochemistry. 13:1974;5135-5141.
17. Clerk A., Bogoyevitch M.A., Andersson M.B., Sugdin P.H. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J. Biol. Chem. 269:1994;32848-32857.
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
19. Hernandez-Alcoceba R., Saniger L., Campos J., Nunez M.C., Khaless F., Gallo M.A., Espinosa A., Lacal J.C. Choline kinase inhibitors as a novel approach for antiproliferative drug design. Oncogene. 15:1997;2289-2301.
20. 2-mediated signalling in neutrophils. Biochim. Biophys. Acta. 1113:1992;135-160.
21. Amtmann E. The antiviral, antitumoral xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. Drugs Exp. Clin. Res. 22:1996;287-294.
22. Luberto C., Hannun Y.A. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J. Biol. Chem. 273:1998;14550-14559.
23. 1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J. Biol. Chem. 271:1996;22297-22300.
24. Stern P.H., Vance D.E. Phosphatidylcholine metabolism in neonatal mouse calvaria. Biochem. J. 244:1987;409-415.